Literature DB >> 30911165

Winning the war with iron.

Suzy V Torti1, Frank M Torti2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30911165      PMCID: PMC8118198          DOI: 10.1038/s41565-019-0419-9

Source DB:  PubMed          Journal:  Nat Nanotechnol        ISSN: 1748-3387            Impact factor:   39.213


× No keyword cloud information.
  11 in total

Review 1.  Iron and Cancer.

Authors:  Suzy V Torti; David H Manz; Bibbin T Paul; Nicole Blanchette-Farra; Frank M Torti
Journal:  Annu Rev Nutr       Date:  2018-08-21       Impact factor: 11.848

2.  Decreased ferroportin promotes myeloma cell growth and osteoclast differentiation.

Authors:  Zhimin Gu; He Wang; Jiliang Xia; Ye Yang; Zhendong Jin; Hongwei Xu; Jumei Shi; Ivana De Domenico; Guido Tricot; Fenghuang Zhan
Journal:  Cancer Res       Date:  2015-04-08       Impact factor: 12.701

3.  Ferroportin and iron regulation in breast cancer progression and prognosis.

Authors:  Zandra K Pinnix; Lance D Miller; Wei Wang; Ralph D'Agostino; Tim Kute; Mark C Willingham; Heather Hatcher; Lia Tesfay; Guangchao Sui; Xiumin Di; Suzy V Torti; Frank M Torti
Journal:  Sci Transl Med       Date:  2010-08-04       Impact factor: 17.956

4.  O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.

Authors:  Joshua D Schoenfeld; Zita A Sibenaller; Kranti A Mapuskar; Brett A Wagner; Kimberly L Cramer-Morales; Muhammad Furqan; Sonia Sandhu; Thomas L Carlisle; Mark C Smith; Taher Abu Hejleh; Daniel J Berg; Jun Zhang; John Keech; Kalpaj R Parekh; Sudershan Bhatia; Varun Monga; Kellie L Bodeker; Logan Ahmann; Sandy Vollstedt; Heather Brown; Erin P Shanahan Kauffman; Mary E Schall; Ray J Hohl; Gerald H Clamon; Jeremy D Greenlee; Matthew A Howard; Michael K Schultz; Brian J Smith; Dennis P Riley; Frederick E Domann; Joseph J Cullen; Garry R Buettner; John M Buatti; Douglas R Spitz; Bryan G Allen
Journal:  Cancer Cell       Date:  2017-08-14       Impact factor: 31.743

Review 5.  The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

Authors:  Tracy R Daniels; Ezequiel Bernabeu; José A Rodríguez; Shabnum Patel; Maggie Kozman; Diego A Chiappetta; Eggehard Holler; Julia Y Ljubimova; Gustavo Helguera; Manuel L Penichet
Journal:  Biochim Biophys Acta       Date:  2011-08-05

Review 6.  Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.

Authors:  Gerda B Toth; Csanad G Varallyay; Andrea Horvath; Mustafa R Bashir; Peter L Choyke; Heike E Daldrup-Link; Edit Dosa; John Paul Finn; Seymur Gahramanov; Mukesh Harisinghani; Iain Macdougall; Alexander Neuwelt; Shreyas S Vasanawala; Prakash Ambady; Ramon Barajas; Justin S Cetas; Jeremy Ciporen; Thomas J DeLoughery; Nancy D Doolittle; Rongwei Fu; John Grinstead; Alexander R Guimaraes; Bronwyn E Hamilton; Xin Li; Heather L McConnell; Leslie L Muldoon; Gary Nesbit; Joao P Netto; David Petterson; William D Rooney; Daniel Schwartz; Laszlo Szidonya; Edward A Neuwelt
Journal:  Kidney Int       Date:  2017-04-20       Impact factor: 10.612

7.  Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.

Authors:  Saeid Zanganeh; Gregor Hutter; Ryan Spitler; Olga Lenkov; Morteza Mahmoudi; Aubie Shaw; Jukka Sakari Pajarinen; Hossein Nejadnik; Stuart Goodman; Michael Moseley; Lisa Marie Coussens; Heike Elisabeth Daldrup-Link
Journal:  Nat Nanotechnol       Date:  2016-09-26       Impact factor: 39.213

8.  Physicochemical properties of ferumoxytol, a new intravenous iron preparation.

Authors:  V S Balakrishnan; M Rao; A T Kausz; L Brenner; B J G Pereira; T B Frigo; J M Lewis
Journal:  Eur J Clin Invest       Date:  2009-04-23       Impact factor: 4.686

Review 9.  Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics.

Authors:  Danuta S Kalinowski; Christian Stefani; Shinya Toyokuni; Tomas Ganz; Gregory J Anderson; Nathan V Subramaniam; Debbie Trinder; John K Olynyk; Anita Chua; Patric J Jansson; Sumit Sahni; Darius J R Lane; Angelica M Merlot; Zaklina Kovacevic; Michael L H Huang; C Soon Lee; Des R Richardson
Journal:  Biochim Biophys Acta       Date:  2016-02-02

10.  Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron.

Authors:  Saroj Vadhan-Raj; William Strauss; David Ford; Kristine Bernard; Ralph Boccia; Joe Li; Lee F Allen
Journal:  Am J Hematol       Date:  2013-09-30       Impact factor: 10.047

View more
  5 in total

Review 1.  Iron and Cancer: 2020 Vision.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Cancer Res       Date:  2020-09-14       Impact factor: 12.701

2.  Potentiodynamic Electrochemical Impedance Spectroscopy of Polyaniline-Modified Pencil Graphite Electrodes for Selective Detection of Biochemical Trace Elements.

Authors:  Adel Yavarinasab; Mostafa Abedini; Hamed Tahmooressi; Sajjad Janfaza; Nishat Tasnim; Mina Hoorfar
Journal:  Polymers (Basel)       Date:  2021-12-22       Impact factor: 4.329

Review 3.  Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle.

Authors:  Yue Huang; Jessica C Hsu; Hyun Koo; David P Cormode
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

Review 4.  Ferroptosis: The Silver Lining of Cancer Therapy.

Authors:  Zhengming Tang; Zhijie Huang; Yisheng Huang; Yuanxin Chen; Mingshu Huang; Hongyu Liu; Q Adam Ye; Jianjiang Zhao; Bo Jia
Journal:  Front Cell Dev Biol       Date:  2021-11-29

Review 5.  Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics.

Authors:  Shengzhe Zhao; Xujiang Yu; Yuna Qian; Wei Chen; Jianliang Shen
Journal:  Theranostics       Date:  2020-05-15       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.